Edward A Barsumian

Title: Edward A. Barsumian: Innovator in Pharmaceutical Chemistry

Introduction

Edward A. Barsumian is a notable inventor based in Danbury, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on the development of innovative compounds that have potential applications in various therapeutic areas.

Latest Patents

Barsumian's latest patents include "Substituted phenylalkyl-(piperazinyl or homopiperazinyl)alkyl thiols" and "Compounds of the formula ##STR1## wherein R is hydrogen or ##STR2## A is alkyl of 1 to 8 carbon atoms; cycloalkyl of 3 to 7 carbon atoms; phenyl; or phenyl mono-, di- or tri-substituted independently with alkyl of 1 to 4 carbon atoms, halogen, trihalomethyl, alkoxy of 1 to 3 carbon atoms, carboxylic acyl of 1 to 3 carbon atoms, carboxyl, (alkoxy of 1 to 3 carbon atoms)carbonyl, nitro, cyano or di(alkyl of 1 to 3 carbon atoms)amino." These patents reflect his expertise in creating complex chemical structures that may lead to new therapeutic agents.

Career Highlights

Edward A. Barsumian is currently employed at Boehringer Ingelheim GmbH, a leading global pharmaceutical company. His role involves research and development, where he applies his knowledge of chemistry to innovate new drug formulations. His contributions have been instrumental in advancing the company's portfolio of pharmaceutical products.

Collaborations

Throughout his career, Barsumian has collaborated with esteemed colleagues, including Karl D. Hargrave and John P. Devlin. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in research.

Conclusion

Edward A. Barsumian is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and advancements in drug development. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.